drugset / Trial / NCT00608803
Phase 1 Study of ZIO-201-T in Combination With Doxorubicin in Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The study of safety of ZIO-201-T in combination with doxorubicin in the treatment of advanced cancer.
Timeline
- Start
- 2008-01
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | palifosfamide-tris | Other / unclassified | — | — |
| Background | Doxorubicin | Other / unclassified | — | — |